Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages.
2025 · 2nd Quarter (Apr 1 - June 30)
CARDINAL HEALTH INC
Filed by CARDINAL HEALTH, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- Not reported
- Expenses
- $420,000.00
- Registrant
- CARDINAL HEALTH, INC.
- Client
- CARDINAL HEALTH INC
- Filing UUID
- 2a4d32ab-2c06-4402-8271-62c6b2b0db9c
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.